Results 181 to 190 of about 92,764 (319)

Dropped jaw as a feature of suspected nutritional encephalopathy in a cat

open access: yesVeterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract A 3‐year‐1‐month‐old female neutered domestic shorthair cat was presented for reluctance to jump over 3 months. Neurological and orthopaedic examinations, laboratory tests and cerebrospinal fluid analysis were unremarkable. Magnetic resonance imaging revealed mild bilateral symmetrical intra‐axial changes in the caudal brainstem.
Eleftheria Skovola   +3 more
wiley   +1 more source

Transient 7‐hour coma following a sacrococcygeal epidural with ropivacaine in a cat

open access: yesVeterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract A 2‐year‐old cat was anaesthetised for pelvic fracture repair. Premedication included methadone 0.2 mg/kg and medetomidine 5 µg/kg intravenously (IV). Anaesthesia was induced with ketamine 2 mg/kg and propofol 1 mg/kg IV and maintained with isoflurane.
Morgane Gavet   +4 more
wiley   +1 more source

Kallikrein-kinin system as a potential target for the treatment of intervertebral disc degeneration. [PDF]

open access: yesEur J Med Res
Lu T   +9 more
europepmc   +1 more source

Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting

open access: yesAsian Journal of Endoscopic Surgery, Volume 19, Issue 1, January/December 2026.
ABSTRACT Background With the increasing use of minimally invasive surgery, understanding of the precise anatomy involved in median arcuate ligament syndrome (MALS) has advanced. However, surgical strategies and treatment principles for MALS remain unclear.
Hidenori Haruta   +14 more
wiley   +1 more source

Immunohistochemical analysis to detect a molecular signature in intervertebral disc degeneration. [PDF]

open access: yesHistochem Cell Biol
Penolazzi L   +7 more
europepmc   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy